End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
7.75
CNY
|
-.--%
|
|
-4.08%
|
-9.78%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
12,880
|
15,659
|
12,862
|
16,221
|
11,693
|
11,949
|
Enterprise Value (EV)
1 |
12,768
|
15,489
|
12,359
|
14,869
|
10,004
|
11,638
|
P/E ratio
|
12
x
|
12.8
x
|
10.2
x
|
8.97
x
|
7.28
x
|
10.1
x
|
Yield
|
2.78%
|
2.93%
|
4.33%
|
4.75%
|
6.57%
|
4.66%
|
Capitalization / Revenue
|
2.3
x
|
2.92
x
|
2.31
x
|
1.81
x
|
1.02
x
|
1.36
x
|
EV / Revenue
|
2.28
x
|
2.88
x
|
2.22
x
|
1.66
x
|
0.87
x
|
1.33
x
|
EV / EBITDA
|
7.47
x
|
8.05
x
|
6.16
x
|
5.65
x
|
3.88
x
|
5.94
x
|
EV / FCF
|
-1,243
x
|
12.8
x
|
8.38
x
|
8.44
x
|
8.86
x
|
-44.1
x
|
FCF Yield
|
-0.08%
|
7.79%
|
11.9%
|
11.8%
|
11.3%
|
-2.27%
|
Price to Book
|
1.97
x
|
2.25
x
|
1.66
x
|
1.8
x
|
1.19
x
|
1.2
x
|
Nbr of stocks (in thousands)
|
1,432,731
|
1,391,945
|
1,391,945
|
1,401,945
|
1,397,071
|
1,391,045
|
Reference price
2 |
8.990
|
11.25
|
9.240
|
11.57
|
8.370
|
8.590
|
Announcement Date
|
3/19/19
|
4/16/20
|
3/29/21
|
3/29/22
|
3/30/23
|
3/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,604
|
5,369
|
5,568
|
8,957
|
11,503
|
8,774
|
EBITDA
1 |
1,710
|
1,924
|
2,005
|
2,632
|
2,578
|
1,960
|
EBIT
1 |
1,281
|
1,446
|
1,505
|
2,059
|
1,900
|
1,259
|
Operating Margin
|
22.86%
|
26.92%
|
27.03%
|
22.99%
|
16.52%
|
14.35%
|
Earnings before Tax (EBT)
1 |
1,292
|
1,441
|
1,497
|
2,075
|
1,820
|
1,296
|
Net income
1 |
1,100
|
1,227
|
1,304
|
1,808
|
1,598
|
1,180
|
Net margin
|
19.63%
|
22.85%
|
23.42%
|
20.19%
|
13.9%
|
13.44%
|
EPS
2 |
0.7469
|
0.8800
|
0.9100
|
1.290
|
1.150
|
0.8500
|
Free Cash Flow
1 |
-10.27
|
1,206
|
1,475
|
1,761
|
1,130
|
-264.2
|
FCF margin
|
-0.18%
|
22.47%
|
26.49%
|
19.67%
|
9.82%
|
-3.01%
|
FCF Conversion (EBITDA)
|
-
|
62.7%
|
73.54%
|
66.93%
|
43.82%
|
-
|
FCF Conversion (Net income)
|
-
|
98.33%
|
113.11%
|
97.41%
|
70.67%
|
-
|
Dividend per Share
2 |
0.2500
|
0.3300
|
0.4000
|
0.5500
|
0.5500
|
0.4000
|
Announcement Date
|
3/19/19
|
4/16/20
|
3/29/21
|
3/29/22
|
3/30/23
|
3/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
112
|
170
|
503
|
1,351
|
1,689
|
311
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-10.3
|
1,206
|
1,475
|
1,761
|
1,130
|
-264
|
ROE (net income / shareholders' equity)
|
16.9%
|
18.2%
|
17.7%
|
21.5%
|
17%
|
12%
|
ROA (Net income/ Total Assets)
|
9.54%
|
10.6%
|
10%
|
11.7%
|
9.77%
|
6.55%
|
Assets
1 |
11,536
|
11,570
|
13,030
|
15,411
|
16,355
|
18,017
|
Book Value Per Share
2 |
4.570
|
5.000
|
5.570
|
6.430
|
7.020
|
7.170
|
Cash Flow per Share
2 |
0.4800
|
0.4800
|
0.6800
|
1.150
|
1.320
|
0.6500
|
Capex
1 |
336
|
501
|
618
|
363
|
360
|
560
|
Capex / Sales
|
5.99%
|
9.33%
|
11.09%
|
4.05%
|
3.13%
|
6.38%
|
Announcement Date
|
3/19/19
|
4/16/20
|
3/29/21
|
3/29/22
|
3/30/23
|
3/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -9.78% | 1.48B | | +3.18% | 101B | | +1.20% | 65.99B | | +44.29% | 41.98B | | +15.99% | 38.65B | | +3.89% | 32.16B | | +6.82% | 19.21B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B |
Other Commodity Chemicals
|